ETFs with PCYC as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.97%||PowerShares Dynamic Biotech &Genome (PBE)||+6.20 (26.78%)|
|3.44%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||+15.12 (17.55%)|
|1.84%||N/A (SHVY)||+0.96 (2.34%)|
|1.8%||N/A (SHMO)||+8.39 (18.37%)|
|1.11%||TrimTabs Float Shrink ETF (TTFS)||+5.47 (16.21%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
On November 14, 2012, the Board of Directors approved a change in the fiscal year end from June 30 to December 31, effective December 31, 2012. All references to "fiscal years", unless otherwise noted, refer to the twelve-month fiscal year, which prior to July 1, 2012, ended on June 30, and beginning on December 31, 2012, ends on December 31, of each year. Company Overview We are a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. ... More ...